InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Discover the detailed record of transactions filed by Swayze Eric, VP Exécutif. Insider active across 1 companies, notably Ionis Pharmaceuticals INC. Aggregated, 6 reports have been logged. Total volume traded: €15k. The latest transaction was disclosed on 1 October 2025 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations6 total
US$648,04114,142 shares@ US$45.82390.0050% mcap100.0% of flow
Common Stock
SEC:0000874015-25-000245·
€648,04114,142 shares@ €45.82390.0050% mcap48.8% of flow
Common Stock
SEC:0000874015-25-000245:0·
€15,402378 shares@ €40.74690.0001% mcap1.2% of flow
Common Stock
SEC:0000874015-22-000101:0·
€15,758621 shares@ €25.3760.0001% mcap1.2% of flow
Common Stock
SEC:0000874015-22-000091:0·
013,809 shares0
Common Stock
SEC:0000874015-22-000050:0·
013,809 shares0
Common Stock
SEC:0000874015-22-000050·
6 of 6 declarations
About Swayze Eric
Eric Swayze is the Executive Vice President of Research at IONIS Pharmaceuticals Inc. He leads the company's research efforts, focusing on the development of innovative new therapies. His leadership is essential in advancing research projects and improving patient outcomes.
